SCYX Q3 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$6M-9846.9% margin

Net Income

$351,000548.4% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$458,000

Balance Sheet

Total Assets

$52M

Total Liabilities

$24M

Stockholders' Equity

$28M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$6M	-$6M	+1.5%
Net Income	$351,000	-$8M	+104.2%

Revenue Segments

License And Service

$100,000100%